Bunge Global SA
CorpDigest
Bunge Global SA
Financial Performance
Last reviewed: July 2025 · By Swet Parvadiya
Revenue
$53.1B
Market Cap
$24.4B
Net Income
$1.1B
Employees
37,000
Bunge's net income fell 49.3% in FY2024 — from $2.24 billion to $1.137 billion — despite revenue declining only 10.8%. The $8.2 billion acquisition of Viterra, completed in July 2025, added 14,000 employees, 29 port terminals, and over 300 facilities across 50+ countries. The revenue history captures commodity price cycles more than anything else: $59.5 billion in 2023, $53.1 billion in 2024, then a surge to $70.3 billion in 2025 as the Viterra consolidation added substantial grain merchandising revenues. Net income of $1.137 billion in 2024 on $53.1 billion in revenue represents a 2.1% net margin — the economics of a scale business where volume and throughput matter far more than per-unit profitability. Bunge's trade structured finance programs generated $36 million in net returns in 2023 through letters of credit and time deposits, monetizing the financial flows embedded in global grain trade. That $36 million is a rounding error in the income statement but illustrates how the company extracts value from every layer of the agricultural supply chain. The Viterra acquisition cost $8.2 billion and required $233 million in integration costs in fiscal 2025 alone — $216 million in SG&A and $28 million in interest expense.
Revenue Trend Analysis
YoY Change
+32.4%
2-Year CAGR
+8.7%
Peak Year
2025
Trend
Mostly Growing
Bunge Global SA has reported revenue across 3 fiscal years, compounding at +8.7% annually over 2 years. The most recent year saw a 32.4% increase versus the prior year. Revenue peaked in 2025 at $70.3B. Out of 2 reported periods, 1 showed growth and 1 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $70.3B | — | +32.4% |
| FY2024 | $53.1B | $1.1B | -10.8% |
| FY2023 | $59.5B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
Bunge's $1.1 billion 2024 net income on $53.1 billion revenue represents 2% net margin — characteristic of commodity trading and processing where massive volumes generate modest per-unit margins requiring scale for absolute profitability. Adjusted EBITDA of $2.5-3 billion (5-6% margin) provides better view of underlying profitability when excluding mark-to-market accounting volatility from commodity hedging positions. The company's profitability fluctuates significantly with commodity cycles — 2022-2023 generated exceptional profits from Russia-Ukraine war disrupting grain flows and creating trading opportunities, while 2024 normalised as conditions stabilised. Long-term return on equity averages 12-15% reflecting the capital intensity of processing infrastructure but consistent demand for food commodities providing earnings sustainability through cycles.
The Viterra merger structure provides Bunge approximately 70% economic ownership of combined entity, with Viterra shareholders (Glencore, CPP) receiving Bunge shares plus $2 billion cash, increasing Bunge's revenue base from $53 billion to $130+ billion combined. Management projects $250 million in annual cost synergies through facility rationalisation, procurement leverage, and operational consolidation, plus revenue synergies from integrated origination and processing operations. Integration costs of approximately $400-500 million through 2026 will pressure near-term earnings, though long-term profitability should benefit from scale advantages. Combined entity carries approximately $10 billion in debt from acquisition financing, increasing leverage but remaining manageable given combined cash flow generation of $3-4 billion annually.
Bunge's earnings exhibit moderate sensitivity to grain and oilseed commodity prices — direct trading positions are hedged through futures markets, but processing margins benefit from volatility (price spreads between input commodities and output products), and asset values fluctuate with grain prices affecting working capital. The 2022 Russia-Ukraine war disruption of Black Sea grain flows generated approximately $1 billion in incremental profits for Bunge as trading volatility and tighter supplies expanded margins, while 2024 stabilisation has compressed earnings back toward normal levels. Long-term grain demand growth from population and dietary upgrading provides revenue tailwinds, though biofuel mandates, climate impacts on agricultural production, and trade policy create medium-term uncertainty. Bunge's diversified portfolio across grains, geographies, and value chain positions provides relative resilience to commodity volatility.
Bunge returns capital through dividends (approximately $2.72 annually per share, 3% yield) and share buybacks of $2-3 billion authorisation, with capital allocation balanced against debt reduction post-Viterra merger and continued infrastructure investment in growth markets. The company has maintained consistent dividend payments for 50+ years, providing income-focused investors stable yield from a cyclical business. Capital allocation discipline reflects management's recognition that commodity businesses require maintaining strong balance sheets through cyclical pressures, with conservative leverage targets (1.5-2.5x EBITDA) preserving financial flexibility. Post-Viterra integration, Bunge's earnings power and cash flow generation should support increased capital returns as cost synergies materialise and operational consolidation completes through 2027.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Bunge Global SA Revenue & Financials." CorpDigest, https://corpdigest.com/company/bunge/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Bunge Global SA reported $70B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/bunge/financials" target="_blank" rel="noopener">CorpDigest — Bunge Global SA financials</a></div>